Related Experiment Videos
Regression kinetics of mouse skin papillomas
Cancer Research
|April 1, 1976
Summary
Stopping promoter treatment initiated skin papilloma regression, with both rapid and slow components observed. Increased promoter dose amplified rapid regression, while papilloma proliferation resisted reversibility.
Area of Science:
- Oncology
- Dermatology
- Carcinogenesis
Background:
- Mouse skin papillomas are a model for tumor development.
- Understanding papilloma regression is crucial for cancer research.
Purpose of the Study:
- To investigate the factors influencing mouse skin papilloma persistence and regression.
- To elucidate the role of promoter dose and irritation in tumor yield.
Main Methods:
- HA/ICR mice were initiated with 7,12-dimethylbenz(a)anthracene and promoted with phorbol myristate acetate.
- Papilloma regression rates were analyzed after promoter treatment cessation.
- Effects of varying promoter dose, antithymocyte serum, and irritants were assessed.
Main Results:
- Papilloma regression exhibited rapid (24-day half-time) and slow (>140-day half-time) components.
- Increased promoter dose enhanced rapid regression; papilloma proliferation indices were irreversible.
- Non-promoting irritants slowed regression, increasing half-time to 57 days.
Conclusions:
- Promoter action can overcome papilloma regression tendencies.
- Promotion frequency and non-specific irritation influence tumor yield.
- Papilloma cell proliferation is resistant to regression signals.